LEADER 01309nam  2200373Ia 450 
001 9910696979603321
005 20230902161650.0
035   $a(CKB)5470000002383093
035   $a(OCoLC)535218904
035   $a(EXLCZ)995470000002383093
100   $a20100301d2005      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $eestimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2005]
215   $a1 electronic resource (27 pages) $cchart
300   $a"Pharmacology and toxicology."
300   $a"July 2005."
320   $aIncludes bibliographical references (pages 13-14).
517   $aGuidance for industry 
606   $aDrugs$xDosage
606   $aDrugs$xTesting
615  0$aDrugs$xDosage.
615  0$aDrugs$xTesting.
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910696979603321
996   $aGuidance for industry$93434577
997   $aUNINA